Enhanced eosinophil trafficking from bone marrow to the tissue is a hallmark of allergic diseases.
We have shown previously that PGI(2) markedly attenuates the locomotion of human eosinophils in vitro. Here, we set out to determine the effect of PGI(2) on the trafficking of bone marrow eosinophils in the guinea pig.
Shape change of bone marrow eosinophils was determined by flow cytometry, and chemotaxis assays were performed using a transwell migration system.
Eosinophil release from bone marrow of guinea pigs was investigated in the isolated, perfused hind-limb preparation.
We found that PGI(2) prevented the mobilization of eosinophils from bone marrow and attenuated the shape change and chemotactic responses of bone marrow eosinophils.
These effects were mimicked by iloprost and were prevented by the IP antagonist CAY10441 and the adenylyl cyclase inhibitor SQ22536. Immunohistochemical staining of bone marrow confirmed the expression of IPs by bone marrow eosinophils.
The rate-limiting enzyme of PGI(2) formation, PGIS, was found in large mononuclear cells.
These data show that IP activation negatively modulates the mobilization and locomotion of bone marrow eosinophils and might therefore also protect against exaggerated recruitment of eosinophils to inflammatory sites.
2011-08-02
Eng.
Institute for Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria. eva.sturm [at] medunigraz.at
J Leukoc Biol. 2011 Aug;90(2):285-91
© Galenicom 1999-2013